Closing Bell: Nervgen Pharma Corp up on Friday (NGEN)

Today in trading, shares of Nervgen Pharma Corp opened at $2.26 and closed at $2.30. It traded at a low of $2.22 to a high of $2.30.

Shares advanced 0.88% from the previous day's close of $2.28.

Today across North America, the TSX Composite closed -0.12% at 21554.86, the S&P 500 closed -0.25% at 5473.17, the Dow Jones Industrial Average closed 0.77% at 39134.76 and the Nasdaq Composite closed -0.79% at 17721.59.

Nervgen Pharma Corp traded under NGEN on the Toronto Venture Exchange (TSX-V).

Trading volume was 14,208 on 39 total trades. On average, Nervgen Pharma Corp has traded 31,551 shares over the last 5-days and 89,204 year-to-date.

Trading across the entire TSX-V saw 2,578 price advancers against 2,634 declines and 115 unchanged.

During the prior 52 weeks, NGEN.VN has traded as high as $3.98 (February 05,2024) and low as $1.58 (December 14,2023). Moreover, the shares have raised 37.72 percent in the last year, while they have shrunken -14.81% year-to-date.

Following today's trading, Nervgen Pharma Corp has a market capitalization of $159.44 million on a float of 69,928 shares outstanding. Its annual EPS is $-0.34.

Nervgen Pharma Corp is a TSX Biotechnology company headquartered in Vancouver, CAN.

Based on 0.00 analysts, Nervgen Pharma Corp gets an average recommendation of "Strong Sell" according to Zacks. Currently, there are for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..